Security key
34960Q307
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 2,786,648
- Total 13F value
- $5,571,004
- Share change
- -1,766,062
- Put/Call ratio
- 26%
- SEC-reported price per share
- $2.00
- Number of holders
- 38
- Value change
- -$5,820,776
- Number of buys
- 19
- Number of sells
- 20
Open additional details 1 more signal available
Report period
Q1 2024
Institutions
38
Top holders
10
FBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 34960Q307
Recent filing periods:
Ownership snapshot
Top reported holders of FBIO - Fortress Biotech, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Holdings, LLC
Disclosed value leader
CVI Holdings, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
3/4/5
Highest disclosed value: $2,301,292
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CVI Holdings, LLC has the largest disclosed position value at $2.3M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CVI Holdings, LLC's linked filing trail.
Disclosed position value
Top 5
CVI Holdings, LLC
$2.3M
Rosalind Advisors, Inc.
$1.83M
ARMISTICE CAPITAL, LLC
$1.79M
Altium Capital Management LLC
$1.22M
Nantahala Capital Management, LLC
$1.12M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Holdings, LLC |
13F
Company
|
—
class O/S missing
|
$2,301,292
764,549 shares
|
— | 31 Dec 2023 |
| Rosalind Advisors, Inc. |
13F
Company
|
—
class O/S missing
|
$1,829,469
607,797 shares
|
— | 31 Dec 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$1,793,960
596,000 shares
|
— | 31 Dec 2023 |
| Altium Capital Management LLC |
13F
Company
|
—
class O/S missing
|
$1,219,417
405,122 shares
|
— | 31 Dec 2023 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
class O/S missing
|
$1,121,412
372,562 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$1,065,218
353,893 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
2,786,648
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
38
Q1 2024 holders
38
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend